Factors Analysis Related to Prolonged Stay in the Pediatric Post-Anesthesia Care Unit(PACU) (PACU)

Prolonged Stay in the Pediatric PACU

The purpose of this study is to determine which factors contribute to prolonged stay of children in the PACU.

Study Overview

• Status: Not yet recruiting
• Conditions: Anesthesia; Adverse Effect

Detailed Description

Studying the factors associated with prolonged stay of children in the PACU is of great significance to the medical team, as it can improve the quality and speed of anesthesia recovery, not only in line with the concept of accelerated rehabilitation surgery, but also through intervention and optimization of specific factors to improve the efficiency of children's postoperative discharge from the PACU, reduce the incidence of complications, lower medical costs, and increase patient and family satisfaction. Therefore, this study aims to explore the factors associated with prolonged stay of children in the PACU through retrospective analysis.

• Study Type: Observational
• Enrollment (Estimated): 10000

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: Child; Adult
• Accepts Healthy Volunteers: N/A

• Sampling Method: Non-Probability Sample

Study Population

Pediatric patient entering the Pediatric Post-Anesthesia Care.

Description

Inclusion Criteria:

• Children aged 0-18 years old; Child entering the Pediatric Post-Anesthesia Care.
• Emergency surgery; Pediatric patients with incomplete medical history; Pediatric patients requiring postoperative ICU care; Pediatric patients with preoperative altered consciousness; Neurological disorders; Severe liver, kidney, lung, and heart diseases.

Study Plan

How is the study designed?

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Anesthesia Plan Selection	Anesthesia options include general anesthesia, combined anesthesia, pure intravenous anesthesia, and nerve block anesthesia.	Day 1
Pain Score	Evaluate pain using the Visual Analog Scale (VAS): 0 points: no pain; 1-3 points: mild pain; 4-6 points: moderate pain; 7-10 points: severe pain.	Day 1
Complications in PACU	Nausea, vomiting, chills, pain, agitation	Day 1
American Society of Anesthesiologists（ASA）	ASA I: Patients in good health, without systemic disease. ASA II: Patients with mild systemic disease, not significantly limiting daily activity. ASA III: Patients with severe systemic disease, with definite functional limitation. ASA IV: Patients with severe systemic disease that is a constant threat to life. ASA V: Moribund patients who are not expected to survive without the operation. ASA VI: Brain-dead patients whose organs are being removed for donation.	Day 1
The medication usage in PACU	Morphine, Propofol, Ketorolac, Fentanyl	Day 1

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
The use of PCA（Patient-Controlled Analgesia）in PACU	PCA usage statistics，yes or no	Day 1

Collaborators and Investigators

• Sponsor: Saiqiang Guo

Study record dates

Study Major Dates

• Study Start (Estimated): May 31, 2024
• Primary Completion (Estimated): December 31, 2024
• Study Completion (Estimated): March 31, 2025

Study Registration Dates

• First Submitted: April 23, 2024
• First Submitted That Met QC Criteria: April 29, 2024
• First Posted (Actual): May 2, 2024

Study Record Updates

• Last Update Posted (Actual): May 3, 2024
• Last Update Submitted That Met QC Criteria: May 1, 2024
• Last Verified: May 1, 2024

More Information

Terms related to this study

• Keywords: Pediatrics; Risk factors; Post-anesthesia care unit
• Other Study ID Numbers: FARPSPP

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No